Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
032 N-(3-{[5-(4-chlorophenyl)-1h-pyrrolo[2,3-B]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 3OG7   PDBj   RCSB PDB   PDBe
Header : transferase/transferase inhibitor
Title : B-Raf Kinase V600E oncogenic mutant in complex with PLX4032
Release Data : 2010-09-22
Compound :
mol_id molecule chains synonym
1 AKAP9-BRAF fusion protein A,B Proto-oncogene B-Raf, p94, v-Raf murine sarcoma viral oncogene homolog B1
ec: 2.7.11.1
fragment: Kinase domain (unp residues 1175-1446)
mutation: I544A, I551K, Q562R, L588N, K630S, F667E, Y673S, A688R, L706S, A688R, L706S, Q709R, S713E, L716E, S720E
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Escherichia coli  (taxid:562)
gene: BRAF, BRAF1, RAFB1
Authors : Zhang, Y., Zhang, K.Y., Zhang, C.
Keywords : B-Raf, BRAF, PROTO-ONCOGENE, V600E, Kinase, TRANSFERASE, transferase-transferase inhibitor complex
Exp. method : X-RAY DIFFRACTION ( 2.4500 Å )
Citation :

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.

Bollag, G.,Hirth, P.,Tsai, J.  et al.
(2010)  Nature  467 : 596 - 599

PubMed: 20823850
DOI: 10.1038/nature09454

Chain : A, B
UniProt : Q5IBP5 (Q5IBP5_HUMAN)
Reaction : -